Company Intelligence Profile

Cotec Healthcare Limited

COTEC HEALTHCARE LIMITED is a Roorkee-based pharmaceutical contract development and manufacturing company making formulations across 24 dosage forms.

CIN: U24232UT1998PLC016093Active

Last updated 26 October 2026

AI OverviewGenerated from public records

COTEC HEALTHCARE LIMITED is a pharmaceutical contract development and manufacturing company based in Roorkee, Uttarakhand. It was incorporated on 22 December 1998 and makes tablets, capsules, injectables and other dosage forms for clients. In FY2024-25 it reported revenue of ₹192.24 Cr and net profit of ₹20.00 Cr. It filed for an IPO on 10 Sep 2025, with a fresh issue of up to ₹295 Cr.

AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.

See what AICA knows about Cotec Healthcare

Deeper analysis, financial signals and peer comparisons.

Book a demo

Company Identity

Registered nameCOTEC HEALTHCARE LIMITED
CINU24232UT1998PLC016093
StatusActive
ListingUnlisted
Incorporated22 December 1998
ROC
Sector (NIC)Pharma & Life Sciences (NIC 24232)
Registered address
  • KH
  • No. 466, Kishanpur, NH-74, Roorkee-Dehradun Highway, Roorkee, Uttarakhand 247661
Authorized capitalRs 100.0 Cr
Paid-up capitalRs 57.1 Cr

Business Overview

  • COTEC HEALTHCARE LIMITED is a contract development and manufacturing company for pharmaceuticals in India.
  • It makes tablets, capsules, injectables, infusions, eye drops, ointments, syrups, oral liquids, ampoules and vials.
  • Its main plant is in Roorkee, Uttarakhand.
  • It was incorporated on 22 December 1998.
  • The company was earlier named Cotec Healthcare Private Limited.

Directors

NameDINRoleAppointed
Harsh Tiwari00161597Managing Director-
Niraj Kumar Shukla06798807Whole-time Director-
Ram Nivas Gupta08660402Director-
Rekha Pant11243962Director-
Ashoka Kumar Singh11103922Director-

Financials

FY2024-25
  • Revenue ₹192.24 Cr
  • EBITDA ₹31.44 Cr
  • Net profit ₹20.00 Cr
FY2023-24
  • Revenue ₹138.00 Cr
  • EBITDA ₹17.12 Cr
  • Net profit ₹10.46 Cr
FY2022-23
  • Revenue ₹82.42 Cr
  • EBITDA ₹9.51 Cr
  • Net profit ₹5.03 Cr

Funding

  • IPO: draft offer document filed with SEBI on 10 Sep 2025.
  • Fresh issue of up to ₹295 Cr, plus an offer for sale by promoters Harsh Tiwari and Vandana Tiwari.
  • Proposed listing on BSE and NSE.

Shareholding

  • Promoters: Harsh Tiwari, Vandana Tiwari

Charges & Borrowings

HDFC Bank₹2 Cr (08 Sep 2026)
HDFC Bank₹20 Cr (10 Jul 2026)
HDFC Bank₹2 Cr (07 Jul 2026)
State Bank of India₹85 Cr (03 Jul 2026)
SIDBI₹2 Cr (06 Jan 2026)
SIDBI₹9.2 Cr (08 May 2025)
SIDBI₹4.4 Cr (09 Oct 2024)
SIDBI₹5 Cr (19 Jan 2023)

Frequently Asked Questions

What does COTEC HEALTHCARE LIMITED do?
It is a pharmaceutical contract development and manufacturing company. It makes tablets, capsules, injectables, infusions, eye drops, ointments, syrups, ampoules and vials for other companies. Its main plant is in Roorkee, Uttarakhand.
When was COTEC HEALTHCARE LIMITED incorporated?
COTEC HEALTHCARE LIMITED was incorporated on 22 December 1998. It was earlier named Cotec Healthcare Private Limited.
Who are the directors of COTEC HEALTHCARE LIMITED?
The directors are Harsh Tiwari (Managing Director), Niraj Kumar Shukla (Whole-Time Director), Ram Nivas Gupta, Dinesh Chandra Pandey, Rekha Pant and Ashoka Kumar Singh.
What is the CIN of COTEC HEALTHCARE LIMITED?
The CIN of COTEC HEALTHCARE LIMITED is U24232UT1998PLC016093.
Where is COTEC HEALTHCARE LIMITED registered?
The registered office is at KH. No. 466, Kishanpur, NH-74, Roorkee-Dehradun Highway, Roorkee, Uttarakhand 247661.

Recur Market

Which lenders fit a company like Cotec Healthcare Limited?

Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.

Similar Pharma & Life Sciences companies

More on Recur Club

Explore on Recur Club

More from Recur Club

Looking for business funding?

Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.

Disclaimer: Company information shown on this page is compiled from public records and third-party sources. It may be incomplete, outdated, or contain inaccuracies, and is provided for general informational purposes only. Please verify details independently before relying on them.